Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FB9RX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,975
Award facts
- Contract value 100% obligated
- $21,974.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,974.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on January 20, 2026, with completion targeted for January 21, 2026. The contract is non-set-aside and performed from the company's location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp operates as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. The provision of Jardiance, a diabetes medication, aligns with the company's extensive portfolio of therapeutic pharmaceuticals delivered across multiple clinical domains. As a major distributor operating on a competitive basis without set-aside designations, the company demonstrates sustained capability to meet federal procurement requirements for brand-name and generic medications essential to military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FB9RX?
SPE2DR26FB9RX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FB9RX worth?
The government has obligated $21,975 on SPE2DR26FB9RX.
Is contract SPE2DR26FB9RX an order under another contract?
Yes. SPE2DR26FB9RX is a delivery order under SPE2DR25D2212, an indefinite delivery contract.
Was contract SPE2DR26FB9RX competed?
The extent of competition for SPE2DR26FB9RX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award